JOHNSON B KRISTINE — SEC insider filings
SEC reporting owner CIK 1231984. 38 insider filings on record with FilingPulse; latest filed 2026-11-10.
Transaction summary — filings shown
Covers all 38 filings on record, filed 2020-10-01 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 80,000 shares, $225,408 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 112,776 shares, $150,643 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 2,452 shares @ $58.48 ($143,393) in AtriCure, Inc., filed 2026-11-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ViewRay, Inc. (VRAY) | Director | 7 | 2 legs · 80,000 sh · $225,408 | 2 legs · 110,324 sh · $7,250 | 3 |
| AtriCure, Inc. (ATRC) | Director | 7 | — | 1 leg · 2,452 sh · $143,393 | 6 |
| ClearPoint Neuro, Inc. (CLPT) | Director | 19 | — | — | 24 |
| Paragon 28, Inc. (FNA) | Director | 5 | — | — | 5 |
Insider filings — JOHNSON B KRISTINE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-10 | 4 | AtriCure, Inc. (ATRC) | Sale (S): 2,452 @ $58.48 | EDGAR |
| 2026-05-26 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 12,820 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | ClearPoint Neuro, Inc. (CLPT) | Option exercise (M): 12,417 · Option exercise (M): 12,417 (derivative) | EDGAR |
| 2026-05-20 | 4 | AtriCure, Inc. (ATRC) | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2025-05-23 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 12,417 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | AtriCure, Inc. (ATRC) | Grant/award (A): 5,401 @ $0 | EDGAR |
| 2025-05-19 | 4 | ClearPoint Neuro, Inc. (CLPT) | Option exercise (M): 21,093 · Option exercise (M): 21,093 (derivative) | EDGAR |
| 2025-04-21 | 4 | Paragon 28, Inc. (FNA) | Disposition to issuer (D): 47,347 | EDGAR |
| 2024-05-21 | 4 | Paragon 28, Inc. (FNA) | Grant/award (A): 15,906 @ $0 | EDGAR |
| 2024-05-17 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 21,093 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | ClearPoint Neuro, Inc. (CLPT) | Option exercise (M): 17,153 · Option exercise (M): 17,153 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | AtriCure, Inc. (ATRC) | Grant/award (A): 7,788 @ $0 | EDGAR |
| 2023-07-24 | 4 | ViewRay, Inc. (VRAY) | Sale (S): 30,702 @ $0.05 | EDGAR |
| 2023-07-20 | 4 | ViewRay, Inc. (VRAY) | Sale (S): 79,622 @ $0.07 | EDGAR |
| 2023-05-26 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 17,153 (derivative) @ $0 | EDGAR |
| 2023-05-26 | 4 | AtriCure, Inc. (ATRC) | Grant/award (A): 3,186 @ $0 | EDGAR |
| 2023-05-19 | 4 | Paragon 28, Inc. (FNA) | Grant/award (A): 8,361 @ $0 | EDGAR |
| 2023-01-04 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 431 @ $7.97 | EDGAR |
| 2022-10-04 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 337 @ $10.19 | EDGAR |
| 2022-07-06 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 272 @ $12.63 | EDGAR |
| 2022-06-15 | 4 | ViewRay, Inc. (VRAY) | Grant/award (A): 54,511 @ $0 | EDGAR |
| 2022-05-27 | 4 | AtriCure, Inc. (ATRC) | Grant/award (A): 3,564 @ $0 | EDGAR |
| 2022-05-27 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 9,269 @ $0 · Grant/award (A): 6,179 (derivative) @ $0 | EDGAR |
| 2022-05-20 | 4 | Paragon 28, Inc. (FNA) | Grant/award (A): 8,918 @ $0 | EDGAR |
| 2022-05-13 | 4/A | ViewRay, Inc. (VRAY) | Purchase (P): 40,000 @ $2.82 | EDGAR |
| 2022-05-12 | 4 | ViewRay, Inc. (VRAY) | Purchase (P): 40,000 @ $2.82 | EDGAR |
| 2022-04-05 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 345 @ $9.96 | EDGAR |
| 2022-01-05 | 4 | ViewRay, Inc. (VRAY) | Grant/award (A): 10,806 @ $5.83 | EDGAR |
| 2022-01-04 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 595 @ $11.54 | EDGAR |
| 2021-12-03 | 4 | Paragon 28, Inc. (FNA) | Grant/award (A): 14,162 @ $0 | EDGAR |
| 2021-10-04 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 383 @ $17.92 | EDGAR |
| 2021-07-02 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 257 @ $20.26 | EDGAR |
| 2021-06-28 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 3,003 @ $0 · Grant/award (A): 6,006 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | ViewRay, Inc. (VRAY) | Grant/award (A): 19,759 @ $0 | EDGAR |
| 2021-05-24 | 4 | AtriCure, Inc. (ATRC) | Grant/award (A): 1,749 @ $0 | EDGAR |
| 2021-04-02 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 255 @ $19.57 | EDGAR |
| 2021-01-04 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 333 @ $15 | EDGAR |
| 2020-10-01 | 4 | ClearPoint Neuro, Inc. (CLPT) | Grant/award (A): 876 @ $5.71 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1231984 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs